Home
>
National Drug Code (NDC)
>
Atovaquone and Proguanil Hydrochloride
Atovaquone and Proguanil Hydrochloride - 43063-393-14 - (Atovaquone and Proguanil Hydrochloride)
Drug Information of Atovaquone and Proguanil Hydrochloride
| Product NDC: | 43063-393 |
| Proprietary Name: | Atovaquone and Proguanil Hydrochloride |
| Non Proprietary Name: | Atovaquone and Proguanil Hydrochloride |
| Active Ingredient(s): | 250; 100 mg/1; mg/1 & nbsp; Atovaquone and Proguanil Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atovaquone and Proguanil Hydrochloride
| Product NDC: | 43063-393 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091211 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110818 |
Package Information of Atovaquone and Proguanil Hydrochloride
| Package NDC: | 43063-393-14 |
| Package Description: | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-393-14) |
NDC Information of Atovaquone and Proguanil Hydrochloride
| NDC Code | 43063-393-14 |
| Proprietary Name | Atovaquone and Proguanil Hydrochloride |
| Package Description | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-393-14) |
| Product NDC | 43063-393 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atovaquone and Proguanil Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110818 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| Strength Number | 250; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
